Experiment 310141

Worktypes

PHARMACOLOGY OF COMPOUND - IN VITRO

Compounds isolated

LANOST-8-EN-23-26-OLIDE,17-ALPHA-23-EPOXY-29-HYDROXY-3-BETA-[(O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-O-[O-BETA-D-GLUCOPYRANOSYL(1-2)-BETA-D-GLUCOPYRANOSYL(1-3)]-O-BETA-D-GLUCOPYRANOSYL(1-2)-ALPHA-L-ARABINOPYRANOSYL(1-6)-BETA-D-GLUCOPYRANOSYL)-OXY]: (23S-25R)

Details

PropertyValue
Pharmacology
CYTOTOXIC ACTIVITY
OrganismChionodoxa luciliae (LILIACEAE)
CitationORI,K: KURODA,M: MIMAKI,Y: SAKAGAMI,H: SASHIDA,Y:. (2003). NORLANOSTANE AND LANOSTANE GLYCOSIDES FROM THE BULBS OF CHIONODOXA LUCILIAE AND THEIR CYTOTOXIC ACTIVITY.. 51(1)
Amount utilized
Compound isolated
DiseaseVS.HSC-2 CELLS.
Dose amount14.0 MCG
Number20
Qualitative resultWEAK ACTIVITY
AnimalCELL CULTURE
Per unitML
Dose expressionIC50